Interferon causes ischemic ocular diseases - Case series and literature review;Interferon löst okuläre ischämien aus - Fallserie und literaturüberblick

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 5, 2006, Pages 367-371

  Stoffelns, Bernhard M ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cotton wool spot; Hepatitis C; Interferon; Retinopathy

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; BLURRED VISION; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETES MELLITUS; HEPATITIS C; HUMAN; HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; KIDNEY CARCINOMA; LEUKEMIA; MELANOMA; METASTASIS; OPHTHALMOLOGY; RETINA HEMORRHAGE; RETINA MACULA EDEMA; RETINOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; VISUAL IMPAIRMENT; EPIDEMIOLOGY; EYE; FEMALE; GERMANY; INCIDENCE; ISCHEMIA; MALE; METHODOLOGY; MIDDLE AGED; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULARIZATION; VISUAL DISORDER;

ADULT; AGED; CAUSALITY; EYE; FEMALE; GERMANY; HUMANS; INCIDENCE; INTERFERON-ALPHA; ISCHEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; VISION DISORDERS;

EID: 33745948751     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926593     Document Type: Conference Paper

References (32)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495
2. Alexander G, Walsh K. Chronic viral hepatitis. Int J Clin Pract 2000; 54: 450-456
3. Bauherz G, Soeur M, Lustman F. Oculomotor nerve paralysis induced by alpha II-interferon. Acta Neurol BeIg 1990; 90: 111-114
4. Becker MD, Heiligenhaus A, Hudde T et al. Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol 2005; 89 (10): 1254-1257
5. Cheney CP, Chopra S, Graham C. Hepatitis C. Infect Dis Clin North Am 2000; 14: 633-667
6. Fujikawa Y, Fujikawa E, Hasebe S et al. A case of recurrent branch retinal vein occlusion following systemic interferon therapy. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1996; 90: 157-159
7. Futami H, Chuuman T, Naoi N et al. Ocular complications during systemic interferon therapy. Jpn J Clin ophthalmol (Rinsho Ganka) 1994; 48: 533-537
8. Guyer DR, Tiedeman J, Yannuzzi LA et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-356
9. Hararda T, Fukami H, Takeuchi T et al. Interferone-assoziierte Retinopathie. Klin Monatsbl Augenheilkd 1995; 207: 302-304
10. Hayasaka S, Fujii M, Yamamoto Y et al. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis recieving interferon alpha. Br J Opthalmol 1995; 79: 150-152
11. Hayasaka S, Nagaki Y, Matsumoto M et al. Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323-325
12. Heintges T, Erhardt A, Wenning M et al. Pegyliertes (PEG-)Interferon. Dtsch Ärztebl 2001; 98: A 182-184 (Heft 4)
13. Heintges T, Erhardt A, Sagir A et al. Kombinationstherapie der chronischen Hepatitis C. Dtsch Ärztebl 2002; 99: A 1239-1241 (Heft 18)
14. Hoerauf H, Schmidt-Erfurth U, Asiyo-Vogel M et al. Combined choroidal and retinal ischemia during interferon therapy: indocyanine green angiographic and microperimetric findings. Arch Ophthalmol 2000; 118: 580-582
15. Ikebe T, Nakatsuka K, Goto M et al. A case of retinopathy induced by intravenous administration of interferon. Folia Ophthalmol Jpn (Ganka-Kiyo) 1990; 41: 2291-2296
16. Pharmacological Therapy for Macular Degeneration Study Group. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Arch Ophthalmol 1997; 115 (7): 865-872
17. Kado M, Yoshida A, Sakagami S. Retinopathy in patients with type C hepatitis during interferon therapy. J Jpn Ophthalmol Assoc (Nipponno-Ganka) 1993; 64: 961-965
18. Klose M, Hopf E, Bleckmann H. Untersuchungen zum Auftreten der Interferon alpha-induzierten Retinopathie. Klin Monatsbl Augenheilkd 1994; 204: 199
19. Kötter I, Eckstein AK, Stubiger N et al. Treatment of ocular symptoms of Behcets disease with interferon alpha 2 a: a pilot study. Br J Ophthalmol 1998; 82: 488-494
20. Miyamoto K, Suda T, Motokura M et al. Retinopathy in interferon-alpha treatment. J Eye (Atarashii Ganka) 1993; 10: 497-500
21. Myers JP, Di Bisceglie AM, Mann ES. Cryoglobulinemia associated with Purtscher-like retinopathy. Am J Ophthal 2001; 131: 802-804
22. Nakamura A, Saitoh M, Mitsudome T et al. Sudden visual impairment in a case under interferon therapy for type C chronic active hepatitis. J Rev Clin Ophthalmol (Ganka Rinsho Iho) 1995; 89: 1386-1389
23. Neubauer AS, Hoops JP. Beidseitige retinale Mikroangiopathie unter Interferon-Therapie bei malignem Melanom der Haut. Klin Monatsbl Augenheilkd 2000; 217: 308-311
24. Norcia F, Di Maria A, Prnadini F et al. Natural interferon therapy: Optic nerve ischemic damage? Ophthalmologica 1999; 213: 339-340
25. Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alpha. Arch Ophthalmol 1995; 113 (8): 1041-1044
26. Rubio Jr JE, Charles S. Interferon-associated combined branch retinal artery and central retinal vein obstruction. Retina 2003; 23 (4): 546-548
27. Schulman JA, Chanping L, Lakshmana MK et al. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 2003; 110: 437-442
28. Seiji H, Yasunori N, Masayuki M et al. Interferon associated retinopathy. Br J Ophthalmol 1998; 82: 323-325
29. Soushi T, Kobayashi F, Obazawa H et al. Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis. J Jpn Ophthalmol Soc (Nichigan-Kaishi) 1996; 100: 69-76
30. Tadokoro Y, Ohtsuki H, Okano M et al. A case of disc edema during systemic interferon therapy. Folia Ophthalmol Jpn (Ganka-Kiyo) 1995; 46: 653-656
31. Tokai R, Ikeda T, Miyaura T et al. Interferon-associated retinopathy and cystoid macular edema. Arch Ophthalmol 2001; 119 (7): 1077-1079
32. Wilson RA. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol 2004; 38 (8): 712-722 Review